Scientists test copycat drug in healthy volunteers
Knowledge-focused
Completed
This study aimed to see if a new manufacturing version of the drug Omalizumab (called Process-Changed CMAB007) behaves similarly to the original drug (Xolair) in the body. It involved 114 healthy Chinese male volunteers who received a single injection. Researchers monitored the p…
Phase: PHASE1 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC